Generic Drug ETF Not So Generic

Ted

FYI: Here are some basic facts: human longevity is rising thanks to the wonders of modern chemistry, and people are increasingly turning to generic drugs for cost reasons when they stock up their medicine cabinet.

While there are numerous mutual funds and exchange-traded funds focused on the pharmaceutical and biotechnology industries, nobody has honed their focus strictly on generic drugs. But with today’s launch of the Market Vectors Generic Drugs ETF (GNRX), the fund’s sponsor, Van Eck Global, says it has rolled out the first ETF targeting global makers of generic drugs and biosimilars.
Regards,
Ted
http://www.fa-mag.com/news/generic-drug-etf-not-so-generic-24607.html?print

M* Snapshot CNRX:
http://www.morningstar.com/etfs/xnas/gnrx/quote.html

heezsafe

Very concentrated medicine: top 10= 48.1% (and, coincidentally, about that much exposure to foreign currencies). Expect virtually no yield from this puppy.

http://www.vaneck.com/market-vectors/equity-etfs/gnrx/Holdings/